NASDAQ: CSCICosciens Biopharma Revenue
Cosciens Biopharma revenue was $9.03M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $1.5M, down 54.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CSCI annual revenue was $9.6M, with 34.2% growth year-over-year.
CSCI past revenue growth
How has CSCI's revenue growth performed historically?
Company
36.51%
Industry
1,361.15%
Market
34.96%
CSCI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CSCI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CSCI's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
CSCI revenue history
Current Revenue
$9.0M
Current Earnings
-$17.6M
Current Profit Margin
-194.5%
Be the first to know when CSCI announces revenue.
CSCI Revenue History By Year
| CSCI Yearly Revenue | CSCI Revenue | CSCI Change | CSCI Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $9.59M | $2.44M | +34.22% |
| 2023-12-31 | $7.14M | -$7.43M | -50.98% |
| 2022-12-31 | $14.57M | $9.31M | +177.03% |
| 2021-12-31 | $5.26M | $1.61M | +44.03% |
| 2020-12-31 | $3.65M | $3.12M | +586.47% |
| 2019-12-31 | $532.00k | -$26.35M | -98.02% |
| 2018-12-31 | $26.88M | $25.96M | +2,812.35% |
| 2017-12-31 | $923.00k | $12.00k | +1.32% |
| 2016-12-31 | $911.00k | $366.00k | +67.16% |
| 2015-12-31 | $545.00k | $534.00k | +4,854.55% |
| 2014-12-31 | $11.00k | -$6.16M | -99.82% |
| 2013-12-31 | $6.18M | $4.12M | +200.78% |
| 2012-12-31 | $2.05M | -$2.65M | -56.37% |
| 2011-12-31 | $4.71M | -$23.00M | -83.02% |
| 2010-12-31 | $27.70M | -$35.53M | -56.19% |
| 2009-12-31 | $63.24M | $24.76M | +64.35% |
| 2008-12-31 | $38.48M | -$3.59M | -8.53% |
| 2007-12-31 | $42.07M | $3.27M | +8.43% |
| 2006-12-31 | $38.80M | -$6.01M | -13.42% |
| 2005-12-31 | $44.81M | $1.84M | +4.28% |
| 2004-12-31 | $42.97M | -$75.77M | -63.81% |
| 2003-12-31 | $118.74M | $40.81M | +52.37% |
| 2002-12-31 | $77.93M | $44.22M | +131.18% |
| 2001-12-31 | $33.71M | $27.24M | +420.84% |
| 2000-12-31 | $6.47M | $1.73M | +36.49% |
| 1999-12-31 | $4.74M | N/A | N/A |
Cosciens Biopharma Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.